Mail & Guardian
Mail & Guardian
stavros nicolaoulatest news & developments
Novo Nordisk’s decision to stop supplying insulin pens to the South African government has drawn criticism across the health sector. Should SA force them and other licence holders to let different manufacturers make insulin pens too? (Canva)
AFRICA

Should SA force big drug makers to let others make insulin pens too?

The pens are running out in public hospitals because of Novo Nordisk’s decision to stop supplying it to the health department

  • Christina Pitt
10 min read
Effort: In an effort to get people vaccinated against Covid-19, Kenya’s health workers go door to door for people who live far from health facilities. The more benign Omnicron variant has also made people complacent. Photo: Briaqn Ongoro/AFP
AFRICA

Africa’s Covid neglect poses global danger

Low vaccination levels and high number of health-compromised populations make the continent a ‘breeding ground for variants’ that pose a global risk

  • Chris Bateman
8 min read
The next three to five years will require the continent to ensure there is sustainable business beyond Covid-19.
ASPEN PHARMACARE

It’s doable: Africa wants 60% of locally manufactured vaccines by 2040

The next three to five years will require the continent to ensure there is sustainable business beyond Covid-19.

  • Marcia Zali
2 min read
ASPEN PHARMACARE

As South Africa’s Covid infections surge, the number of jabs can’t increase, yet

Hospitals are under strain, nurses are burning out and infections are on the rise, but there are limited Covid-19 vaccine doses available

  • Chris Bateman
5 min read
Simon Ntsiman gets his vaccination shot at the FF Robeiro Clinic at Sammy Marks Square vaccination site on May 25, 2021 in Pretoria, South Africa. This forms part of phase 1 b and phase 2 rollout of the COVID-19 vaccine. Under phase 2, citizens aged 60 and above and other vulnerable groups are eligible to get the jab, while healthcare workers who were not vaccinated during phase 1 of the rollout may still do so under phase 1 b. The Gauteng province increased vaccination sites in an effort to ramp up vaccination drive. (Photo by Alet Pretorius/Gallo Images via Getty Images)
ALEX WELTE

Slow registration delays South Africa’s vital vaccine roll-out

This has resulted in demand exceeding supply — or vice versa — at many vaccination sites

  • Chris Bateman
4 min read
A healthcare worker holds an injection syringe of the phase 3 vaccine trial, developed against the novel coronavirus pandemic by the US Pfizer and German BioNTech company, at the Ankara University Ibni Sina Hospital in Ankara, Turkey on October 27, 2020. (Photo by Dogukan Keskinkilic/Anadolu Agency via Getty Images)
ADRIAN GORE

This is how medical aid schemes will help to fund SA’s vaccines

Medical aid schemes and businesses will help the government with the cost of acquiring enough vaccines for the South African population to achieve herd immunity

  • Tshegofatso Mathe
3 min read